Lita Uthaithammarat

Bangkok, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Corneal Biomechanics Before and After Descemet Membrane Endothelial Keratoplasty in Patients with Fuchs Endothelial Corneal Dystrophy.

Corneal Biomechanics Before and After Descemet Membrane Endothelial Keratoplasty in Patients with Fuchs Endothelial Corneal Dystrophy.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: January 25, 2026

Low-level light therapy as an adjunct to intense pulsed light for lipid layer thickness improvement in meibomian gland dysfunction: A randomized trial.

Low-level light therapy as an adjunct to intense pulsed light for lipid layer thickness improvement in meibomian gland dysfunction: A randomized trial.

Journal: The ocular surface

Published: December 31, 2025

First Case Report Of Letendraea helminthicola Endophthalmitis After Penetrating Ocular Trauma from a Cat Scratch.

First Case Report Of Letendraea helminthicola Endophthalmitis After Penetrating Ocular Trauma from a Cat Scratch.

Journal: Ocular immunology and inflammation

Published: October 16, 2025

Mycobacterium haemophilum necrotising keratitis in a cornea with no prior surgical intervention.

Mycobacterium haemophilum necrotising keratitis in a cornea with no prior surgical intervention.

Journal: BMJ case reports

Published: April 08, 2025

Randomized, double-masked, sham-controlled trial of efficacy and safety of quantum molecular resonance for treating meibomian gland dysfunction.

Randomized, double-masked, sham-controlled trial of efficacy and safety of quantum molecular resonance for treating meibomian gland dysfunction.

Journal: Eye (London, England)

Published: June 05, 2024

Anti-inflammatory effect of curcuminoids and their analogs in hyperosmotic human corneal limbus epithelial cells.

Anti-inflammatory effect of curcuminoids and their analogs in hyperosmotic human corneal limbus epithelial cells.

Journal: BMC complementary medicine and therapies

Published: November 27, 2023

Efficacy of Interleukin-1β Inhibitor on Dry Eye Disease in Patients with Degenerative Arthritis.

Efficacy of Interleukin-1β Inhibitor on Dry Eye Disease in Patients with Degenerative Arthritis.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: May 02, 2023

Author Correction: Lack of HPV in pterygium with no evidence of autoinoculation and the role of cytokines in pterygium with dry eye.

Author Correction: Lack of HPV in pterygium with no evidence of autoinoculation and the role of cytokines in pterygium with dry eye.

Journal: Scientific reports

Published: May 05, 2021

Effectiveness and Safety of Combined Application of Three Modes of 2940-nm Erbium:YAG and 1064-nm Neodymium:YAG Lasers in Treatment of Meibomian Gland Dysfunction.

Effectiveness and Safety of Combined Application of Three Modes of 2940-nm Erbium:YAG and 1064-nm Neodymium:YAG Lasers in Treatment of Meibomian Gland Dysfunction.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: April 29, 2021

Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A.

Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: February 08, 2021

Lack of HPV in pterygium with no evidence of autoinoculation and the role of cytokines in pterygium with dry eye.

Lack of HPV in pterygium with no evidence of autoinoculation and the role of cytokines in pterygium with dry eye.

Journal: Scientific reports

Published: August 15, 2020

Efficacy of topical bevacizumab 0.05% eye drops in dry eye disease: A double-masked, randomized trial.

Efficacy of topical bevacizumab 0.05% eye drops in dry eye disease: A double-masked, randomized trial.

Journal: PloS one

Published: February 09, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026